previous compound ID: 2626 next compound
InChIKey: XQFRJNBWHJMXHO-RRKCRQDMSA-N
SMILES: C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "JW Hanrahan" "D Rotin" "J Goepp" "DY Thomas" "R Robert" "GW Carlile" "B Kus" "J Liao" "E Matthes"

chemical graph of compound 2626





CID is 5905
synonyms found at PubChem are:
idoxuridine, 5-Iodo-2'-deoxyuridine, 54-42-2, 5-Iododeoxyuridine, Idoxuridin, Iododeoxyridine, Iodoxuridine, IUDR, Joddeoxiuridin, Idoxene, Allergan 211, IDUR, Virudox, 5IUDR, (+)-5-Iodo-2'-deoxyuridine, Idoxuridinum, Antizona, Idoxuridina, Heratil, Allergan 201, Idossuridina [DCIT], IDU, Herpid, Herplex, Stoxil, Iduoculos, Dendrid, IdUrd, Iduridin, Kerecid, 2'-Deoxy-5-iodouridine, Herplex liquifilm, Idoxuridinum [INN-Latin], Idoxuridina [INN-Spanish], Ophthalmadine, Spectanefran, Herpesil, Iduviran, Emanil, Herpidu, Idexur, Iducher, Idulea, Synmiol, 5IdU, Idu Oculos, SK&F-14287, 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil, 1beta-D-2'-Deoxyribofuranosyl-5-iodouracil, 1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil, 5-Iodouracil deoxyriboside, Iododeoxyuridine, Allergan-211, UNII-LGP81V5245, C9H11IN2O5, CCRIS 2827, URIDINE, 2'-DEOXY-5-IODO-, CHEBI:147675, 5-IUDR, EINECS 200-207-8, NSC-39661, BRN 0030397, Idossuridina, Kerecide, (+)-5-Iodo-2-deoxyuridine, AI3-50861, Oftan-IDU, LGP81V5245, NSC 39661, Uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-, Uridine, 5-iodo-2'-deoxy-, 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione, ID2, SKF 14287, SK&F 14287, DSSTox_CID_25238, DSSTox_RID_80769, DSSTox_GSID_45238, Herpes-Gel, (+)-5-Iodo-2 -deoxyuridine, Herpe-Gel, 5-Iododesoxyuridine, Idoxuridine [USAN:INN:BAN:JAN], Dendrid (TN), 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione, HERPLEX (TN), 5-I-2'-dUrd, SR-05000001510, HSDB 7479, CAS-54-42-2, NCGC00016243-01, 5-Iodo-deoxyuridine, 33995-05-0, Idoxuridine [USAN:USP:INN:BAN:JAN], 5-iodo-2'deoxyuridine, Idoxuridine (5-IdU), PubChem14202, Prestwick3_000018, CHEMBL788, D02IED, Epitope ID:138107, AC1L1LE0, AC1Q77TF, SCHEMBL3683, BSPBio_000055, 4-24-00-01235 (Beilstein Handbook Reference), MLS002154175, 5-IODO-2-DEOXYURIDINE, BPBio1_000061, Idoxuridine (JP17/USP/INN), DTXSID2045238, SCHEMBL15850897, CTK4D1152, AOB5602, MolPort-001-792-514, XQFRJNBWHJMXHO-RRKCRQDMSA-N, HMS2090M10, HMS2095C17, HMS2230E10, HMS3712C17, HY-B0307, KS-00000JH7, ZINC3834173, Tox21_110324, ANW-32073, BDBM50370388, MFCD00134656, s1883, AKOS015920431, Tox21_110324_1, (+)-5-Iodo-2'-deoxyuridine, 98%, AC-8219, CCG-220018, CS-2346, DB00249, MCULE-5585466189, SMP2_000072, uridine, 2'-deoxy-5-(iodo-131I)-, NCGC00179673-01, NCGC00179673-03, AJ-45810, AK-35587, AS-13469, BR-35587, CJ-10798, I381, SC-16201, SMR001233472, AB0013659, AX8021350, DB-009133, LS-160825, TL8003566, 5-Iodo-2'-deoxyuridine, >=99% (HPLC), I0258, 1-(2-Deoxy- -D-ribofuranosyl)- 5-iodouracil, C-1149, D00342, 16509-EP2281563A1, 16509-EP2316459A1, 20495-EP2272827A1, 20495-EP2298768A1, 20495-EP2314585A1, 134I656, J-009907, J-700180, SR-05000001510-1, SR-05000001510-3, SR-05000001510-4, BRD-K76634210-001-14-7, Idoxuridine, European Pharmacopoeia (EP) Reference Standard, Idoxuridine, United States Pharmacopeia (USP) Reference Standard, 2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-iodo-, 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione, 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione, 1336-77-2, 888-04-0